← All companies

VRCA

Verrica Pharmaceuticals Inc.

VRCA Nasdaq Pharmaceutical Preparations EDGAR ↗

$5.25

-0.01 -0.19%

Key statistics

from XBRL data in SEC filings

Market cap

$90.2M

Revenue (TTM)

$37.2M

Net income (TTM)

-$17.8M

EPS (TTM)

$-1.10

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

$20.6M

Total assets

$38.8M

Gross margin

—

52-week range

$3.28 – $9.82

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change; Shareholder vote results Jun 9, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Results of operations (earnings release) May 12, 2026 10-K Fiscal year ended 2025-12-31 Mar 11, 2026 8-K Results of operations (earnings release) Mar 11, 2026 8-K Director or officer change Dec 30, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Nov 24, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Results of operations (earnings release) Nov 14, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release); Other events Aug 12, 2025 8-K Delisting notice or listing-rule failure Jul 30, 2025 8-K Modified rights of security holders Jul 23, 2025 8-K Entered a material agreement; Regulation FD disclosure Jul 1, 2025 8-K Entered a material agreement Jun 12, 2025 8-K Shareholder vote results Jun 5, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Results of operations (earnings release) May 13, 2025 8-K Director or officer change Apr 25, 2025 8-K Director or officer change Apr 2, 2025 10-K Fiscal year ended 2024-12-31 Mar 11, 2025 8-K Results of operations (earnings release) Mar 11, 2025 8-K Entered a material agreement Feb 21, 2025 8-K Delisting notice or listing-rule failure Jan 30, 2025 8-K Director or officer change Dec 9, 2024 8-K Entered a material agreement; Other events Nov 21, 2024 8-K Other events Nov 20, 2024 10-Q Quarter ended 2024-09-30 Nov 5, 2024 8-K Results of operations (earnings release); Director or officer change Nov 4, 2024 8-K Delisting notice or listing-rule failure; Director or officer change Oct 8, 2024 8-K Exit or disposal costs Oct 1, 2024 8-K Director or officer change Sep 27, 2024 8-K Director or officer change Sep 6, 2024 8-K Director or officer change Aug 27, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 14, 2024 8-K Entered a material agreement Aug 5, 2024 8-K Entered a material agreement Jun 28, 2024 8-K Shareholder vote results Jun 10, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure May 15, 2024